Synaptic Vesicle Protein

Updated: 2026-07-15

Overview

Synaptic vesicle proteins are a group of specialized proteins embedded in the membranes of synaptic vesicles, which are small sacs that store neurotransmitters in neurons. These proteins play pivotal roles in neurotransmitter release during synaptic transmission, including vesicle docking, fusion, and recycling. Key members include synaptobrevin (VAMP), synaptophysin, and synaptotagmin. Research on these proteins has advanced our understanding of synaptic plasticity and neurological disorders such as Parkinson's disease and epilepsy. In pharmaceutical development, they serve as targets for neuroactive drugs and diagnostic markers. Their study requires high-purity isolates, often produced via recombinant DNA technology for consistency.

Physical and Chemical Properties

Most synaptic vesicle proteins are integral membrane proteins with hydrophobic domains that anchor them to vesicle membranes. Their molecular weights range from 15-40 kDa, and their structures often include SNARE motifs or calcium-binding domains (e.g., C2 domains in synaptotagmin). These proteins exhibit pH-dependent solubility and are typically stabilized in buffers containing glycerol or detergents. They are sensitive to proteolytic degradation, requiring storage at low temperatures. Analytical techniques like SDS-PAGE and Western blotting are standard for purity verification, while circular dichroism (CD) spectroscopy assesses secondary structure integrity.

Main Applications

In neuroscience research, synaptic vesicle proteins are used to study exocytosis mechanisms, synaptic plasticity, and vesicle trafficking. They are critical tools for investigating neurodegenerative diseases; for example, alpha-synuclein interactions with these proteins are linked to Parkinson's pathology. Pharmaceutical companies target these proteins to develop drugs for epilepsy (e.g., botulinum toxins cleaving VAMP) and depression. Diagnostic assays leverage antibodies against synaptophysin or VAMP to detect synaptic dysfunction in cerebrospinal fluid. Emerging applications include bioengineered vesicles for drug delivery systems.

Safety and Storage

While generally non-toxic, handling synaptic vesicle proteins requires standard lab precautions: gloves, lab coats, and eye protection. Avoid inhalation of lyophilized powder. Contaminants (e.g., endotoxins) may be present in native preparations, requiring vendor certification. Store lyophilized proteins at -20°C or -80°C; reconstituted solutions should be aliquoted to minimize freeze-thaw cycles. Buffers often include protease inhibitors (e.g., PMSF) and reducing agents (e.g., DTT) to prevent degradation. Shipping requires dry ice for stability.

B2B Procurement Guide

When procuring synaptic vesicle proteins, prioritize vendors with ISO 9001 certification and batch-specific QC data. Key specifications include purity (>95% by SDS-PAGE), concentration (verified by UV absorbance), and biological activity (e.g., binding assays). Recombinant proteins offer consistency but may lack post-translational modifications; native proteins are suited for functional studies but vary by tissue source. Bulk orders (10+ mg) commonly attract 15-30% discounts. Lead times range from 2-6 weeks for custom preparations. Request MSDS and stability data for regulatory compliance.